NO20076517L - Natriumsalter av 5-[4-[2-(N-metyl-N-(2-pyridyl)amino)etoksyl]benzyl]tiazolidin-2,4-dion - Google Patents

Natriumsalter av 5-[4-[2-(N-metyl-N-(2-pyridyl)amino)etoksyl]benzyl]tiazolidin-2,4-dion

Info

Publication number
NO20076517L
NO20076517L NO20076517A NO20076517A NO20076517L NO 20076517 L NO20076517 L NO 20076517L NO 20076517 A NO20076517 A NO 20076517A NO 20076517 A NO20076517 A NO 20076517A NO 20076517 L NO20076517 L NO 20076517L
Authority
NO
Norway
Prior art keywords
thiazolidine
pyridyl
benzyl
amino
methyl
Prior art date
Application number
NO20076517A
Other languages
English (en)
Inventor
Andrew Simon Craig
Michael Millan
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO20076517L publication Critical patent/NO20076517L/no
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

En forbindelse 5-[4-[2-(N-metyl-N-(2-pyridyl)aniino)etoksy]-benzyl]tiazolidin-2,4-dion natriumsalt eller et farmasøytisk akseptabelt solvat derav, kjennetegnet ved at natriumsaltet er ikke-hygroskopisk eller svakt hygroskopisk; en farmasøytisk sammensetning som inneholder en slik foibindelse og anvendelse av en slik forbindelse innen medisin.
NO20076517A 2000-09-29 2007-12-18 Natriumsalter av 5-[4-[2-(N-metyl-N-(2-pyridyl)amino)etoksyl]benzyl]tiazolidin-2,4-dion NO20076517L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0023971.5A GB0023971D0 (en) 2000-09-29 2000-09-29 Novel pharmaceutical
PCT/GB2001/004334 WO2002026735A1 (en) 2000-09-29 2001-09-28 Sodium salts of 5-'4-'2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione

Publications (1)

Publication Number Publication Date
NO20076517L true NO20076517L (no) 2003-04-29

Family

ID=9900428

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20031435A NO20031435L (no) 2000-09-29 2003-03-28 Natriumsalter av 5-[4-[2-(N-metyl-N-(2- pyridyl)amino)etoksy]benzyl]tiazolidin-2,4-dion
NO20076517A NO20076517L (no) 2000-09-29 2007-12-18 Natriumsalter av 5-[4-[2-(N-metyl-N-(2-pyridyl)amino)etoksyl]benzyl]tiazolidin-2,4-dion

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20031435A NO20031435L (no) 2000-09-29 2003-03-28 Natriumsalter av 5-[4-[2-(N-metyl-N-(2- pyridyl)amino)etoksy]benzyl]tiazolidin-2,4-dion

Country Status (27)

Country Link
US (4) US20040014752A1 (no)
EP (2) EP1813612A1 (no)
JP (1) JP2004509959A (no)
KR (1) KR100917953B1 (no)
CN (4) CN101125852A (no)
AP (1) AP1738A (no)
AU (2) AU2001292028B2 (no)
BG (1) BG107679A (no)
BR (1) BR0114308A (no)
CA (1) CA2423975A1 (no)
CZ (1) CZ302181B6 (no)
DZ (1) DZ3480A1 (no)
EA (1) EA005109B1 (no)
EC (1) ECSP034528A (no)
GB (1) GB0023971D0 (no)
HU (1) HUP0301188A3 (no)
IL (2) IL155051A0 (no)
MA (1) MA25912A1 (no)
MX (1) MXPA03002868A (no)
NO (2) NO20031435L (no)
NZ (1) NZ524933A (no)
OA (1) OA12399A (no)
PL (1) PL363701A1 (no)
SK (1) SK3782003A3 (no)
UA (1) UA74842C2 (no)
WO (1) WO2002026735A1 (no)
ZA (1) ZA200302439B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8133637B2 (en) * 2005-10-06 2012-03-13 Headwaters Technology Innovation, Llc Fuel cells and fuel cell catalysts incorporating a nanoring support
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
AU2010331926B2 (en) * 2009-12-15 2014-03-27 Cirius Therapeutics, Inc. PPAR-sparing thiazolidinediones and combinations for the treatment of neurodegenerative diseases

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2137915T3 (es) * 1987-09-04 2000-01-01 Beecham Group Plc Derivados de tiazolidindiona sustituida.
GB9124513D0 (en) * 1991-11-19 1992-01-08 Smithkline Beecham Plc Novel process
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9308487D0 (en) * 1993-04-23 1993-06-09 Smithkline Beecham Plc Novel compounds
GB9723295D0 (en) * 1997-11-04 1998-01-07 Smithkline Beecham Plc Novel process
CN1253236A (zh) * 1998-11-11 2000-05-17 李扬远 一种以重力差释放引力能的方法
CN1183130C (zh) * 1999-09-24 2005-01-05 中国人民解放军军事医学科学院毒物药物研究所 噻唑烷类衍生物及其医药用途
HU225919B1 (en) * 1999-12-18 2007-12-28 Richter Gedeon Nyrt Thiazolidine-derivatives, process for their preparation pharmaceutical and intermediates
GB0006133D0 (en) * 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
WO2002026735A1 (en) 2002-04-04
ZA200302439B (en) 2004-04-28
US20040214866A1 (en) 2004-10-28
HUP0301188A2 (hu) 2003-11-28
CZ302181B6 (cs) 2010-12-01
BR0114308A (pt) 2003-10-14
NZ524933A (en) 2004-12-24
EP1813612A1 (en) 2007-08-01
SK3782003A3 (en) 2004-06-08
CN1466585A (zh) 2004-01-07
PL363701A1 (en) 2004-11-29
JP2004509959A (ja) 2004-04-02
US20040014752A1 (en) 2004-01-22
AU9202801A (en) 2002-04-08
DZ3480A1 (fr) 2002-04-04
AP2003002767A0 (en) 2003-03-31
CN1915992B (zh) 2010-05-12
MXPA03002868A (es) 2004-12-06
KR100917953B1 (ko) 2009-09-21
CN1915992A (zh) 2007-02-21
NO20031435L (no) 2003-05-27
UA74842C2 (en) 2006-02-15
HUP0301188A3 (en) 2005-04-28
EA200300422A1 (ru) 2003-08-28
ECSP034528A (es) 2003-05-26
MA25912A1 (fr) 2003-10-01
US20060004058A1 (en) 2006-01-05
CA2423975A1 (en) 2002-04-04
AU2001292028B2 (en) 2005-04-21
IL155051A0 (en) 2003-10-31
CZ2003850A3 (cs) 2004-03-17
US20050277679A9 (en) 2005-12-15
IL188116A0 (en) 2008-03-20
CN101125853A (zh) 2008-02-20
CN101125852A (zh) 2008-02-20
AP1738A (en) 2007-05-07
CN100345846C (zh) 2007-10-31
US20070185167A1 (en) 2007-08-09
OA12399A (en) 2004-09-06
EA005109B1 (ru) 2004-10-28
KR20030039377A (ko) 2003-05-17
NO20031435D0 (no) 2003-03-28
EP1332142A1 (en) 2003-08-06
GB0023971D0 (en) 2000-11-15
BG107679A (bg) 2003-12-31

Similar Documents

Publication Publication Date Title
AP1545A (en) Hydrochloride salts of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione.
CY1106226T1 (el) Μεσυλικο αλας 5-[4-[2-(ν-μεθυλ-ν-(2-πυριδυλ)αμινο)αιθοξυ]βενζυλ]θειαζολιδινο-2,4-διονης
NO20076517L (no) Natriumsalter av 5-[4-[2-(N-metyl-N-(2-pyridyl)amino)etoksyl]benzyl]tiazolidin-2,4-dion
CY1105354T1 (el) Ένα παραγωγο θειαζολιδινοδιονης και η χρηση του σαν αντι-διαβητικο
RS50136B (sr) Derivati tiazolidindiona i njihova upotreba kao antidijabetika
NO20075507L (no) Tiazolidindionderivater og deres anvendelse som antidiabetiske midler
DK1446404T3 (da) Rosiglitazonedisylater og deres anvendelse som antidiabetika
BR0112981A (pt) Sais tartarato de derivado de tiazolidinadiona
ECSP034505A (es) La sal de clorhidrato de 5-[4-(2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2, 4-diona
BR0112982A (pt) Sal tartarato de derivado de tiazolidinadiona
BR0111536A (pt) Sal de tiazolidinediona para tratamento de diabetes mellitus
DK1315721T3 (da) Et Thiazolidindionderivat og dets anvendelse som et antidiabetisk middel
DK1448559T3 (da) 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)thiazolodin-2,4-dionbenzensulfat; fremgangsmåde til dets fremstilling; polymorf i, II og III deraf; og dets anvendelse som farmaceutisk aktiv bestenddel
BR0112984A (pt) Sais tartarato de derivado de tiazolidinodiona
AP2002002684A0 (en) 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
NO20030531L (no) Tartratsalter av tiazolidindionderivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application